Nicotine: Benefits Official Narratives Ignore

Tobacco benefits science actually recognizes

What tobacco benefits are being hidden from us? The question sounds like conspiracy theory fodder, but scientific literature on nicotine confirms the alkaloid has real effects on the brain. The issue isn't whether they exist, but why no one advertises them. The answer lies in taxes, pensions, and a decades-long cultural war demonizing cigarettes.

How nicotine affects the brain

Nicotine stimulates acetylcholine receptors, improving working memory, concentration, and mood. Several studies suggest neuroprotective effects against degenerative diseases like Parkinson's and Alzheimer's, with indications of protection against ulcerative colitis. Some publications even claim it increases testosterone, which might explain the official discourse's fixation on demonizing it. A crucial nuance: these are effects of the alkaloid, not industrial cigarette smoke, loaded with tar and carcinogens.

Don't confuse the container with the content. As analysis often repeats, cured tobacco leaves and multinational cigarettes with additives are distinct products. Natural tobacco, used in moderation, bears little resemblance to the lead and polonium mix sold at shops.

The cash register: Why the State doesn't ban tobacco

If smoking is so harmful, why isn't it banned? Economic arguments explain it: taxes make up around 80% of the final price. A daily pack costing €5 over 50 years puts about €73,000 into public coffers per smoker. The bill doesn't end there: smokers die on average 15 years earlier, concentrated at retirement age. Result: each smoker not only funds the State but saves it 15 years of pension payments. Pure fiscal engineering.

The narrative of hospital costs justifying anti-tobacco laws crumbles when viewing the full balance. Healthcare expenses don't offset tax revenue and pension savings. Put simply, power benefits from your continued smoking.

The episode propaganda buried: Tobacco and ELbichito

Early in the pandemic, doctors from Paris's central hospital and Chinese physicians published surprising data: smokers had a 70% to 80% lower risk of developing severe ELbichito-19 forms. News circulated worldwide, and an urgent investigation for a nicotine-based drug was announced. Then, silence. Nothing more was heard, even as the mRNA vaccine race peaked.

Benevolent explanations cite haste to dismiss dangerous advice; less benevolent ones point to a research line inconvenient to industry and dominant narratives.

Pure tobacco versus industrial tobacco

The difference between sun-dried plants and factory products is vast. Commercial cigarettes contain not just tar, but lead and polonium. Thus, some argue potential nicotine benefits are lost in burning adulterated products. Natural tobacco, home-grown or herbalist-sourced, resembles the herb indigenous people offered Columbus more than industrial goods.

Curiosity: Actor Val Kilmer, known for smoking, suffered throat cancer, but his brand remains unpublished. A detail pure tobacco advocates won't miss.

The fierce taxation on tobacco, unprecedented for other consumer goods, fuels suspicion that demonization is primarily about control and revenue. While some calculate saved pensions, others seek natural, illegal tobacco. Perfect irony.